Latest Breaking News On - Accelerating medicines - Page 1 : comparemela.com

Altering cellular interactions around amyloid plaques may offer novel Alzheimer s treatment strategies

Researchers made a significant breakthrough in Alzheimer s disease research by identifying a novel way to potentially slow down or even halt disease progression. The study, which focuses on the role of reactive astrocytes and the plexin-B1 protein in Alzheimer s pathophysiology, provides crucial insights into brain cell communication and opens the door to innovative treatment strategies.

Hongyan zouRoland friedelNational institute on agingMedicines partnership alzheimer disease target discoveryAssociate professorIcahn mount sinaiBin zhangResearch professorAccelerating medicinesTarget discoveryPreclinical validation

Andelyn Tapped as Viral Vector Manufacturer for NIH Foundation

Andelyn Tapped as Viral Vector Manufacturer for NIH Foundation
genengnews.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from genengnews.com Daily Mail and Mail on Sunday newspapers.

Matt niloffAndelyn biosciencesCourtney silverthornBespoke gene therapy consortiumFoundation for the national institutes of healthMedicines partnershipNational institutesAccelerating medicines

Lifesaving Gene Therapies: Will They Reach Those Who Need Them Most?

Lifesaving Gene Therapies: Will They Reach Those Who Need Them Most?
genengnews.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from genengnews.com Daily Mail and Mail on Sunday newspapers.

United statesEuropean unionFrench muscular dystrophy associationBespoke gene therapy consortiumMedicines partnershipAccelerating medicines

Forge Biologics Joins Consortium to Develop and Manufacture AAV Gene Therapies for Rare Diseases

Researchers want to streamline the drug development process to reduce costs and enable companies to bring more gene therapies to patients.

Courtney silverthornMedicines partnershipFoundation for the national institutes of healthBespoke gene therapy consortiumForge biologicsChristopher shillingNational institutesAccelerating medicines

Nemours Children s Health selected to conduct first gene therapy clinical trial for Morquio A syndrome

As part of the Foundation for the National Institutes of Health Accelerating Medicines Partnership Bespoke Gene Therapy Consortium, Nemours Children's Health has been chosen to conduct a first-of-its-kind gene therapy clinical trial for Morquio A syndrome.

United statesShunji tomatsuAllison bradfordKimberly kipnerMichaelb boberDanielle ellisStuart mackenzieBespoke gene therapy consortiumDrug administrationA cure for robert incNational institutes of healthResearch lab managerNemours children healthClinical researchClinical research coordinatorMedicines partnership